(c)iStock.com/Kwangmoozzaa

A recently published research paper by healthcare technology provider Validic states that the global pharma and biotech will increasingly turn to digital health tools over the next five years to better collect, analyse and act on patient-generated health data (PGHD). This growth is attributed to increased pressures to reduce trials costs, streamline processes, demonstrate real world-efficacy, address medication adherence and improve treatments for chronic diseases.

The survey results in the paper reveal that over 60% of respondents have used digital health technologies in clinical trials and over 97% are planning to use these tools increasingly over the next five years.

The survey was conducted over two months and includes responses from nearly 200 global pharma and biotech companies, as well as technology providers. Most respondents held executive leadership positions closely followed by clinical operations professionals, innovation team members and information technology personnel.

It analysed survey results and market trends to find out the key drivers that is prompting the induction and utilisation of digital health technologies such as, wearables, in-home clinical devices, sensors and apps.

Findings from the survey highlight the increasing prevalence of technology-driven clinical trials and growing need for automated access to real-time, remotely-collected patient data.

Validic CEO and co-founder Drew Schiller said: “The use of digital health technologies and patient-generated health data is becoming a proven necessity to the operational efficiency and patient-centricity of the pharmaceutical industry. This remotely-collected data has the potential to reduce patient burden allowing for more passive engagement and data collection, while also improving the accuracy of data patients contribute during and after trials.”

 

Interested in hearing industry leaders discuss subjects like this and sharing their IoT use-cases? Attend the IoT Tech Expo World Series events with upcoming shows in Silicon Valley, London and Amsterdam to learn more.

The show is co-located with the AI & Big Data Expo, Cyber Security & Cloud Expo and Blockchain Expo so you can explore the entire ecosystem in one place.